Or even if he doesn't do it 24 hours ahead, he had a bunch
Or even if he doesn't do it 24 hours ahead, he had a bunch of questions ahead of time from registrations that he could just start compiling as Nader is speaking. I am keenly aware when a question is asked multiple times...he doesn't seem to be...and that is the problem. Each time he acts like it is a big surprise "oh wow...we have 500 callers...Nader, how should we handle this?" I have submitted this feedback on their survey multiple times. Get assistants to feed you questions if this is too much work for you to do in realtime. It comes across as very unprofessional. And don't even bother with audio questions if it's too cumbersome and clunky.
That being said, Nader and Dr. Patterson worked well together today. Hopefully they took that positive feedback from the last call and realized that preparing ahead of time can lead to a much more polished act. The last two have been great in terms of coordination. Dr. Patterson gives that perfect amount of technical in the weeds detail and Nader gives the high level overview and updates.
One guest asked a great question on when are we going to be covered by the Fox News, CNNs, etc. I feel like this has been dodged a couple of times now if I am being honest. Dr. Patterson said it was criminal on the last call and Nader basically said "nobody believes us because we are the little guy" on this one. I do wish that they would turn around and engage with their PR firm a bit more on this and hold them accountable. It all comes down to validation. Validation via media (the Fox News, CNNs, etc). FDA (BLA, BTD), big banks (financing deal), big pharma (NASH Deal)...we should be pursuing external validation on all fronts ferociously imo as one will hopefully influence the others.
Anyhow, my .02 We will get there...lots of exciting catalysts in the next couple of weeks!!
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Leadership Move at Ten Four Truck Insurance Ten Four Truck Insurance, recognized as a premier provider of insurance solutions tailored specifically for the trucking industry, has recently elevated Chris Johnstone to the position of Director of Partnerships. This strategic appointment is set to enhance the company's collaborative efforts and broaden its partner...
Continue Reading
Revolutionizing the Concrete Construction Process In the bustling world of construction, efficiency is key. An inventive mind has recently introduced a specialized screed hook that promises to streamline the concrete pouring process significantly. This innovation is designed with a focus on ease of use, making it a practical addition for contractors and workers alike....
Continue Reading
SCR Expands Offerings Through Global Partnerships In recent developments, SCR has made significant strides in enhancing its Offshore Company Formation services by forging international partnerships. These collaborations provide businesses and individuals with increased flexibility in establishing structures that can facilitate asset protection, succession planning, and...
Continue Reading
Response Pharmaceuticals Makes Significant Progress in Clinical Trial Response Pharmaceuticals, Inc., a company specializing in innovative weight management solutions, has announced a pivotal moment in its clinical trajectory. The firm has completed early enrollment in a Phase 2 clinical trial assessing the efficacy of its investigational drug candidate, RDX-002. This...
Continue Reading
Fifth Third Bancorp Reports Lower Profits Amid Rising Provisions Fifth Third Bancorp (NASDAQ: FITB), a prominent financial institution, has reported a decrease in its profits for the third quarter, primarily influenced by heightened provisions for loan losses. The bank's recent financial disclosures have caught the attention of investors, culminating in a nearly 3% drop...
Continue Reading